{"schema_version":"secwatch.filing_event.v1","accession":"0001274737-25-000023","form_type":"8-K","ticker":"XGN","cik":"0001274737","company_name":"EXAGEN INC.","filed_at":"2025-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.812773+00:00","generated_at":"2026-05-22T16:41:23.073316+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Exagen Q1 revenue record $15.5M, but net loss widens to $3.8M","bullets":["Revenue $15.5M (+7.5% YoY); net loss $(3.8)M vs $(3.4)M; adjusted EBITDA $(2.5)M vs $(2.0)M.","Trailing-12-month ASP rose to $419 from $377; AVISE CTD test volume grew.","FY2025 guidance: revenue at least $65M; targeting positive adjusted EBITDA in Q4 2025.","Closed $25M senior secured credit facility with Perceptive Advisors on April 25, 2025.","Combined cash and AR projected ~$28M as of April 30 after releasing held claims."],"urls":{"canonical":"https://secwatch.observer/filing/0001274737-25-000023","json":"https://secwatch.observer/filing/0001274737-25-000023.json","markdown":"https://secwatch.observer/filing/0001274737-25-000023.md","text":"https://secwatch.observer/filing/0001274737-25-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1274737/000127473725000023/0001274737-25-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1274737/000127473725000023/exdx-20250505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T16:41:23.073316+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}